Dedicated to providing advanced treatments and comprehensive care for bleeding disorders.

Factor VIII replacement therapy is essential for individuals with Hemophilia A. This treatment helps prevent and control bleeding by providing the missing clotting factor in the blood.

Factor VII replacement therapy is crucial for patients with Factor VII deficiency. It helps manage bleeding disorders by restoring the ability to form clots effectively.

Factor IX replacement therapy is crucial for patients with Factor VII deficiency. It helps manage bleeding disorders by restoring the ability to form clots effectively.

Treatment for Von Willebrand Disease focuses on increasing levels of the Von Willebrand factor and Factor VIII in the blood, ensuring proper clotting and reducing bleeding episodes.

Hemlibra (emicizumab) is a prophylactic treatment for hemophilia A, designed to mimic the action of factor VIII and promote blood clotting.
Contact us today to learn more about our services and how we can support you or your loved ones.
Contact Us